High-efficiency retroviral vector mediated gene transfer into human peripheral blood CD4+ T lymphocytes

Gene Therapy

Volumn 3, Issue 8, 1996, Pages 695-705

  Rudoll, T ^a   Phillips, K ^a   Lee, S W ^a   Hull, S ^a   Gaspar, O ^a   Sucgang, N ^a   Gilboa, E ^a   Smith, C ^a,b,c  

^a DUKE UNIVERSITY   (United States)

^b Department of Health ^*  (Philippines)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Human CD4+ T lymphocytes; Retroviral vector

Indexed keywords

CD4 ANTIGEN; NERVE GROWTH FACTOR RECEPTOR;

ARTICLE; EXPRESSION VECTOR; FLUORESCENCE ACTIVATED CELL SORTER; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; NONHUMAN; NORMAL HUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RETROVIRUS; T LYMPHOCYTE;

3T3 CELLS; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CRYOPRESERVATION; EVALUATION STUDIES; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; LYMPHOCYTE ACTIVATION; MICE; RECEPTOR, NERVE GROWTH FACTOR; RECEPTORS, NERVE GROWTH FACTOR; RETROVIRIDAE; SEQUENCE DELETION; TIME FACTORS;

UNIDENTIFIED RETROVIRUS;

EID: 0029784051     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Blaese RM. Progress toward gene therapy. Clin Immunol Immunopathol 1991; 61: S47-S55.
2. Cournoyer D. Gene therapy of the immune system. Ann Rev Immunol 1993; 11: 297-329.
3. Culver KW, Anderson WF, Blaese RM. Lymphocyte gene therapy. Hum Gene Ther 1991; 2: 107-109.
4. Culver K et al. Lymphocytes as cellular vehicles for gene therapy in mouse and man. Proc Natl Acad Sci USA 1991; 88: 3155-3159.
5. Tiberghien P et al. Gandclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: an approach for specific in vivo donor T cell depletion after bone marrow transplantation. Blood 1994; 84: 1333-1341.
6. Treisman J et al. Interleukin-2-transduced lymphocytes grow in an autocrine fashion and remain responsive to antigen. Blood 1995; 85: 139-145.
7. Liu JH, Wei S, Blanchard DK, Djeu JY. Restoration of lytic function in a human natural killer cell line by gene transfection. Cell Immunol 1994; 156: 24-35.
8. Culver KW et al. Correction of ADA deficiency in human T lymphocytes using retroviral-mediated gene transfer. Transplant Proc 1991; 23: 170-171.
9. Ferrari G et al. Transfer of the ADA gene into human ADA-deficient T lymphocytes reconstitutes specific immune functions. Blood 1992; 80: 1120-1124.
10. Kasid A et al. Human gene transfer: characterization of human tumor-infiltrating lymphocytes as vehicles for retroviral-mediated gene transfer in man. Proc Natl Acad Sci USA 1991; 87: 473-477.
11. Hwu P, Rosenberg SA. The genetic modification of T cells for cancer therapy: an overview of laboratory and clinical trials. Cancer Detect Prevent 1994; 18: 43-50.
12. + human T cell subsets derived from tumor-infiltrating lymphocytes and peripheral blood mononuclear cells. Cancer Immunol Immunother 1991; 32: 342-352.
13. Lee SW, Gallardo HF, Gilboa E, Smith C. Inhibition of human immunodeficiency virus type 1 in human T cells by a potent Rev response element decoy consisting of the 13-nucleotide minimal Rev-binding domain. J Viral 1994; 68: 8254-8264.
14. Leavitt MC et al. Transfer of an anti-HTV-1 ribozyme gene into primary human lymphocytes. Hum Gene Ther 1994; 5: 1115-1120.
15. Chambers CA, Kang J, Hozumi N. Ectopic lymphokine gene expression in human peripheral blood lymphocytes in vivo. Proc Natl Acad Sci USA 1992; 89: 1026-1030.
16. Fukayama M et al. Respiratory tract gene transfer. J Biol Chem 1991; 266: 18339-18344.
17. Nishihara K et al. Augmentation of tumor targeting in a line of glioma-specific mouse cytotoxic T lymphocytes by retroviral expression of mouse γ-interferon complementary DNA. Cancer Res 1988; 48: 4730-4735.
18. Fauser AA. Long-term expression of gene introduction into normal human T lymphocytes by retroviral-mediated gene transfer. J Cell Biochem 1991; 45: 353-358.
19. Mavilio F et al. Peripheral blood lyphocytes as target cells of retroviral vector-mediated gene transfer. Blood 1994; 83: 1988-1997.
20. Strair RK, Towle M, Heald PW, Smith BR. Retroviral mediated transfer and expression of exogenous genes in primary lymphoid cells: assaying for a viral transactivator activity in normal and malignant cells. Blood 1990; 76: 1201-1208.
21. Muro-Cacho CA, Samulski RJ, Kaplan D. Gene transfer in human lymphocytes using a vector based on adeno-associated virus. J Immunother 1992; 11: 231-237.
22. Burkholder JK, Decker J, Yang NS. Rapid transgene expression in lymphocyte and macrophage primary cultures after particle bombardment-mediated gene transfer. J Immunol Meth 1993; 165: 149-156.
23. Hui KM, Sabapathy TK, Oei AA, Chia TF. Generation of alloreactive cytotoxic T lymphocytes by particle bombardment-mediated gene transfer. J Immunol Meth 1994; 171: 147-155.
24. Woffendin C et al. Nonviral and viral delivery of a human immunodeficiency virus protective gene into primary human T cells. Proc Natl Acad Sci USA 1994; 91: 11581-11585.
25. Miller AD. Human gene therapy comes of age. Nature 1992; 357: 455-460.
26. Brenner MK. Gene transfer into human hematopoietic progenitor cells: a review of current clinical protocols. J Hematother 1993; 2: 7-17.
27. Kerr WG, Mule JJ. Gene therapy: current status and future prospects. J Leukocyte Biol 1994; 56: 210-214.
28. Wilson JM et al. Correction of CD18-deficient lymphocytes by retrovirus-mediated gene transfer. Science 1990; 248: 1413-1416.
29. Finer MH et al. Kat: a high-efficiency retroviral transduction system for primary human T lymphocytes. Blood, 1994; 83: 43-50.
30. Correll PH, Colilla S, Karlsson S. Retroviral vector design for long-term expression in murine hematopoietic cells in vivo. Blood 1994; 84: 812-822.
31. Kotani H et al. Improved methods of retroviral vector transduction and production for gene therapy. Hum Gene Ther 1994; 5: 19-28.
32. Springett GM et al. Infection efficiency of T lymphocytes with amphotropic retroviral vectors is cell cycle dependent. J Virol 1989; 63: 3865-3869.
33. Bunnell BA, Muul LM, Donahue RE, Blaese RM, Morgan RA. High efficiency retroviral mediated gene transfer into human and non-human peripheral blood lymphocytes. Proc Natl Acad Sci USA 1995; 92: 7739-7743.
34. Hantzopoulos P, Sullenger B, Ungers G, Gilboa E. Improved gene expression upon transfer of the adenosine deaminase minigene outside the transcriptional unit of a retroviral vector. Proc Natl Acad Sci USA 1989; 86: 3519-3523.
35. Smith C et al. Development of a lacZ marked WEHI-3B D+ murine leukemic cell line as an in vivo model of acute non-lymphocytic leukemia. Leukemia 1993; 7: 310-317.
36. Kim DG, Kang HM, Jang SK, Shin HS. Construction of a bifunctional mRNA in the mouse by using the internal ribosomal entry site of the encephalomyocarditis virus. Molec Cell Biol 1992; 12: 3636-3643.
37. Li M et al. Comparison of the expression of a mutant DHFR under control of different internal promoters in retroviral vectors. Hum Gene Ther 1992; 3: 381-390.
38. Markowitz D, Goff S, Bank A. Construction of a safe and efficient retrovirus packaging cell line. Adv Exp Med Biol 1988; 241: 35-40.